Vanessa Rustler1, Julia Däggelmann2, Fiona Streckmann2,3, Wilhelm Bloch2, Freerk T Baumann4. 1. Institute of Cardiovascular Research and Sports Medicine, Department of Molecular and Cellular Sports Medicine, German Sport University Cologne, Am Sportpark Müngersdorf 6, 50933, Cologne, Germany. v.rustler@dshs-koeln.de. 2. Institute of Cardiovascular Research and Sports Medicine, Department of Molecular and Cellular Sports Medicine, German Sport University Cologne, Am Sportpark Müngersdorf 6, 50933, Cologne, Germany. 3. Department of Sport, Exercise and Health, University of Basel, Basel, Switzerland. 4. Department 1 of Internal Medicine, Center for Integrated Oncology Cologne/Bonn, University Hospital Cologne, Cologne, Germany.
Abstract
PURPOSE: Low levels of physical activity often observed in pediatric oncology might be attributed to various functional deficits, especially those of the lower limbs as these affect gait, mobility, and, consequently, physical activity. In the past few years, whole-body vibration (WBV) has emerged as a new therapy modality for improving physical functioning. Although WBV is increasingly applied in children with disabilities, its impact on lower limb function in pediatric cancer patients and survivors has not yet been investigated. METHODS: To establish whether there is evidence that WBV may be beneficial for pediatric cancer patients and survivors, this review summarizes current data on WBV studies among children with disabilities and extracts relevant information for the pediatric cancer population. Two independent reviewers performed a systematic literature search following the PRISMA guidelines. RESULTS: Nine studies were included in the analysis. Results demonstrate that WBV is a safe, highly compliant, and effective approach in cohorts of children with disabilities. The largest effects of WBV were observed in lower extremity muscle mass and strength, balance control, gait, and walking ability. Furthermore, we were able to develop first recommendations for WBV protocols. CONCLUSIONS: WBV seems to be feasible and effective for improving parameters that may be relevant to the pediatric cancer population. Efforts are needed to conduct first WBV interventions in children with cancer proving the effects. The developed recommendations for WBV protocols might help to implement these intervention studies.
PURPOSE: Low levels of physical activity often observed in pediatric oncology might be attributed to various functional deficits, especially those of the lower limbs as these affect gait, mobility, and, consequently, physical activity. In the past few years, whole-body vibration (WBV) has emerged as a new therapy modality for improving physical functioning. Although WBV is increasingly applied in children with disabilities, its impact on lower limb function in pediatric cancerpatients and survivors has not yet been investigated. METHODS: To establish whether there is evidence that WBV may be beneficial for pediatric cancerpatients and survivors, this review summarizes current data on WBV studies among children with disabilities and extracts relevant information for the pediatric cancer population. Two independent reviewers performed a systematic literature search following the PRISMA guidelines. RESULTS: Nine studies were included in the analysis. Results demonstrate that WBV is a safe, highly compliant, and effective approach in cohorts of children with disabilities. The largest effects of WBV were observed in lower extremity muscle mass and strength, balance control, gait, and walking ability. Furthermore, we were able to develop first recommendations for WBV protocols. CONCLUSIONS: WBV seems to be feasible and effective for improving parameters that may be relevant to the pediatric cancer population. Efforts are needed to conduct first WBV interventions in children with cancer proving the effects. The developed recommendations for WBV protocols might help to implement these intervention studies.
Entities:
Keywords:
Children with disabilities; Pediatric cancer; Pediatric oncology; Vibration; WBV
Authors: Tim Takken; Patrick van der Torre; Marlies Zwerink; Erik H Hulzebos; Marc Bierings; Paul J M Helders; Janjaap van der Net Journal: Psychooncology Date: 2009-04 Impact factor: 3.894
Authors: A Hartman; M L te Winkel; R D van Beek; S M P F de Muinck Keizer-Schrama; H C G Kemper; W C J Hop; M M van den Heuvel-Eibrink; R Pieters Journal: Pediatr Blood Cancer Date: 2009-07 Impact factor: 3.167
Authors: Todd A Florin; G Edgar Fryer; Thomas Miyoshi; Michael Weitzman; Ann C Mertens; Melissa M Hudson; Charles A Sklar; Karen Emmons; Andrea Hinkle; John Whitton; Marilyn Stovall; Leslie L Robison; Kevin C Oeffinger Journal: Cancer Epidemiol Biomarkers Prev Date: 2007-07 Impact factor: 4.090